Clinical and Molecular Hepatology10.3350/cmh.2018.0072201925174-85Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolizationKittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth,,
CardioVascular and Interventional Radiology10.1007/s00270-019-02365-92019433423-433Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular CarcinomaThanate Kattipatanapong, Hideyuki Nishiofuku, Toshihiro Tanaka, Takeshi Sato, Tetsuya Masada, Shota Tatsumoto, Takeshi Matsumoto, Kimihiko Kichikawa,,
Korean Journal of Radiology10.3348/kjr.2015.16.5.106820151651068Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?Hyo-Jin Kang, Young Il Kim, Hyo-Cheol Kim, Hwan Jun Jae, Saebeom Hur, Jin Wook Chung,,
Liver Cancer10.1159/000512337202110163-71Feasibility and Techniques of Securing 3D-Safety Margin in Superselective Transarterial Chemoembolization to Improve Local Tumor Control for Small Hepatocellular Carcinoma: An Intend-to-Treat AnalysisChing Charoenvisal, Toshihiro Tanaka, Hideyuki Nishiofuku, Hiroshi Anai, Takeshi Sato, Takeshi Matsumoto, Nagaaki Marugami, Kimihiko Kichikawa,
Oncology10.1159/000333269201181Suppl. 1105-110Superselective Transarterial Chemoembolization for Hepatocellular Carcinoma: Recent Progression and PerspectiveKenichi Takayasu,,
Hepatology Research10.1111/hepr.136112021513313-322Usefulness of virtual parenchymal perfusion software visualizing embolized areas to determine optimal catheter position in superselective conventional transarterial chemoembolization for hepatocellular carcinomaShiro Miyayama, Masashi Yamashiro, Rie Ikeda, Junichi Matsumoto, Nobuhiko Ogawa, Naoko Sakuragawa,,
HPB10.1016/j.hpb.2016.02.754201618e294-e295Pathological response to pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resectionK.Y. Paik,
Journal of Vascular and Interventional Radiology10.1016/j.jvir.2018.01.3122018294S1214:21 PM Abstract No. 281 Long-term outcomes in superselective transarterial chemoembolization using lipiodol with 3D: safety margin versus radiofrequency ablation for solitary small hepatocellular carcinomaT. Matsumoto, H. Nishiofuku, T. Tanaka, T. Sato, T. Masada, S. Tatsumoto, K. Kichikawa,
Journal of Vascular and Interventional Radiology10.1016/j.jvir.2016.04.01420162791269-1278Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and OutcomeShiro Miyayama, Osamu Matsui,
Hepatology Research10.1111/j.1872-034x.2009.00610.x2010401105-107Combination of transarterial chemoembolization and percutaneous local ablation therapy for hepatocellular carcinoma,